Volume 42, Issue 12 1 pp. 4046-4053
Original Scientific Report

Primary Tumor Versus Liver-First Approach for Synchronous Colorectal Liver Metastases: An Association Française de Chirurgie (AFC) Multicenter-Based Study with Propensity Score Analysis

Francesco Esposito

Francesco Esposito

Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Henri Mondor Hospital, Université Paris-Est (UPEC), 51 Avenue de Lattre de Tassigny, 94010 Créteil, France

Search for more papers by this author
Chetana Lim

Chetana Lim

Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Henri Mondor Hospital, Université Paris-Est (UPEC), 51 Avenue de Lattre de Tassigny, 94010 Créteil, France

Search for more papers by this author
Antonio Sa Cunha

Antonio Sa Cunha

Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Paul Brousse Hospital, Villejuif, France

Search for more papers by this author
Patrick Pessaux

Patrick Pessaux

Institut Hospitalo-Universitaire, Institute for Minimally Hybrid Invasive Image-Guided Surgery, Université de Strasbourg, Strasbourg, France

Institut de Recherche sur les Cancers de l’Appareil Digestif (IRCAD), Strasbourg, France

Search for more papers by this author
Francis Navarro

Francis Navarro

Department of Surgery, Saint-Eloi Hospital, Université de Montpellier, Montpellier, France

Search for more papers by this author
Daniel Azoulay

Corresponding Author

Daniel Azoulay

Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Henri Mondor Hospital, Université Paris-Est (UPEC), 51 Avenue de Lattre de Tassigny, 94010 Créteil, France

INSERM, U955, Créteil, France

Tel.: + 33 1 49 81 25 48, [email protected]Search for more papers by this author
On behalf of the French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC)

French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC)

Search for more papers by this author
Cyril CosseDelphine LignierJean Marc RegimbeauJulien BarbieuxEmilie LermiteAntoine HamyFrançois MauvaisChristophe LaurentIrchid Al NaasanDaniel AzoulayChady SalloumPhilippe CompagnonChetana LimMohammed Sbai IdrissiFréderic MartinJerôme AtgerJacques BaulieuxBenjamin DarnisJean Yves MabrutVahan KepenekianJulie PerinelMustapha AdhamOlivier GlehenMichel RivoireJean HardwigsenAnais PalenEmilie GrégoireYves Patrice LeTreutJean Robert DelperoOlivier TurriniAstrid HerreroFrancis NavarroFabrizio PanaroAhmet AyavLaurent BreslerPhilippe RauchFrançois GuilleminFréderic MarchalJean GugenheimAntonio IannelliStephane BenoistAntoine BrouquetMarc PocardRéa Lo DicoBrice GayetDavid FuksOlivier ScattonOlivier SoubraneJean-Christophe Vaillant

Jean-Christophe Vaillant

Search for more papers by this author
Tullio PiardiDaniel SommacaleReza KianmaneshMichel ComyPhilippe BachellierElie OussoultzoglouPietro AddeoDimitrios NtourakisPatrick PessauxDidier MutterJacques MarescauxLoïc RaouxBertrand SucFabrice MuscariGeorges ElhomsyMaximiliano GelliAntonio Sa CunhaRené AdamDenis CastaingDaniel CherquiGabriella PittauOriana CiacioEric VibertDominique EliasDiane GoéreFabrizio Vittadello
First published: 14 June 2018
Citations: 23

Francesco Esposito and Chetana Lim are co-first authors.

Members of the French Colorectal Liver Metastases Working Group are co-authors of this study and can be found in the Acknowledgements section.

Electronic supplementary material: The online version of this article (https://doi.org/10.1007/s00268-018-4711-x) contains supplementary material, which is available to authorized users.

Abstract

Objectives

Multicenter studies comparing the reverse strategy (RS) with the classical strategy (CS) for the management of stage IVA liver-only colorectal cancer (CCR) are scarce. The aim of this study was to compare long-term survival and recurrence patterns following use of the CS and RS.

Method

This retrospective multicenter review collected data from all consecutive patients with stage IVA liver-only CCR who underwent staged resection of CCR and liver metastases (LM) at 24 French hospitals between 2006 and 2013 and were retrospectively analyzed. Patients who underwent simultaneous liver and CCR resection, those with synchronous extrahepatic metastasis, and those who underwent emergent CCR resection were excluded. Overall survival (OS) and recurrence-free survival (RFS) rates and recurrence patterns were investigated before and after propensity score matching (PSM).

Results

A total of 653 patients were included: 587 (89.9%) in the CS group and 66 (10.1%) in the RS group. Compared with the CS patients, RS patients were more likely to have rectal cancer (43.9 vs. 24.9%; p = 0.006), larger liver tumor size (52.5 ± 38.6 vs. 39.6 ± 30 mm; p = 0.01), and more positive lymph nodes (62.1 vs. 44.8%; p = 0.009). OS was not different between the two groups (75 vs. 72% at 5 years; p = 0.77), while RFS was worse in the RS group (24 vs. 33% at 5 years; p = 0.01). Time to recurrence at any site (1.8 vs. 2.4 years, p = 0.024) and intrahepatic recurrence (1.7 vs. 2.2 years, p = 0.014) were significantly shorter in the RS group than in the CS group. After PSM (63 patients in each group), no significant difference was found between the two groups in OS (p = 0.35), RFS (p = 0.62), time to recurrence at any site (p = 0.19), or intrahepatic recurrence (p = 0.13).

Conclusions

In this study, approximately 10% of patients with CCR and synchronous LM were offered surgery with the RS. Both strategies ensured similar oncological outcomes.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.